# Zai Lab Ltd: filings

ZLAB · Nasdaq · CIK 1704292 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zlab.md) · [Financials](/companies/zlab/financials.md) · [Filings](/companies/zlab/filings.md) · [Insiders](/companies/zlab/insiders.md)

## Reports and events: 163 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 256, 144 116, 8-K 72, 6-K 55, SC 13G/A 29, 3 21, 10-Q 17, CORRESP 16, UPLOAD 16, SC 13G 13, SCHEDULE 13G/A 13, 424B5 8, DEF 14A 7, DEFA14A 7, PRE 14A 7, 10-K 6, 4/A 6, S-8 6, SCHEDULE 13G 6, F-1/A 5, ARS 4, CT ORDER 4, DRSLTR 4, 20-F 3, 20-F/A 3, 5 3, DRS/A 3, EFFECT 3, 3/A 2, 424B2 2, 424B4 2, 8-K/A 2, DRS 2, F-1 2, S-3ASR 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 424B3 1, 8-A12B 1, F-1MEF 1, F-3ASR 1, POSASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 06:06 ET | [8-K](/filings/0001628280-26-066969.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-066969 |
| 2026-08-06 | 10:40 ET | [10-Q](/filings/0001628280-26-053793.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053793 |
| 2026-08-06 | 10:34 ET | [8-K](/filings/0001628280-26-053791.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053791 |
| 2026-06-17 | 20:05 ET | [8-K](/filings/0001628280-26-043869.md) | 5.07 Shareholder vote results | 0001628280-26-043869 |
| 2026-05-21 | 21:18 ET | [8-K](/filings/0001628280-26-037387.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-037387 |
| 2026-05-07 | 10:09 ET | [10-Q](/filings/0001628280-26-031626.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031626 |
| 2026-05-07 | 10:05 ET | [8-K](/filings/0001628280-26-031624.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031624 |
| 2026-04-28 | 11:16 ET | [DEF 14A](/filings/0001704292-26-000030.md) | Proxy statement, period 2026-06-17 | 0001704292-26-000030 |
| 2026-02-26 | 12:08 ET | [10-K](/filings/0001704292-26-000015.md) | Annual report, period 2025-12-31 | 0001704292-26-000015 |
| 2026-02-26 | 12:04 ET | [8-K](/filings/0001704292-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001704292-26-000014 |
| 2025-11-06 | 12:06 ET | [10-Q](/filings/0001704292-25-000024.md) | Quarterly report, period 2025-09-30 | 0001704292-25-000024 |
| 2025-11-06 | 12:04 ET | [8-K](/filings/0001704292-25-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001704292-25-000023 |
| 2025-10-16 | 20:05 ET | [8-K](/filings/0001704292-25-000014.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001704292-25-000014 |
| 2025-08-07 | 10:23 ET | [10-Q](/filings/0001628280-25-038548.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038548 |
| 2025-08-07 | 10:18 ET | [8-K](/filings/0001628280-25-038547.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038547 |
| 2025-06-18 | 20:04 ET | [8-K](/filings/0001628280-25-032099.md) | 5.07 Shareholder vote results | 0001628280-25-032099 |
| 2025-05-08 | 10:11 ET | [10-Q](/filings/0001628280-25-023411.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023411 |
| 2025-05-08 | 10:09 ET | [8-K](/filings/0001628280-25-023410.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023410 |
| 2025-04-29 | 12:04 ET | [DEF 14A](/filings/0001628280-25-020478.md) | Proxy statement, period 2025-06-18 | 0001628280-25-020478 |
| 2025-02-27 | 11:20 ET | [10-K](/filings/0001628280-25-008409.md) | Annual report, period 2024-12-31 | 0001628280-25-008409 |
| 2025-02-27 | 11:13 ET | [8-K](/filings/0001628280-25-008406.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008406 |
| 2025-01-03 | 21:17 ET | [8-K](/filings/0001628280-25-000261.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-000261 |
| 2024-11-15 | 22:23 ET | [8-K](/filings/0001193125-24-259957.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-259957 |
| 2024-11-13 | 21:05 ET | [8-K](/filings/0001628280-24-047588.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-047588 |
| 2024-11-12 | 11:55 ET | [10-Q](/filings/0001628280-24-046824.md) | Quarterly report, period 2024-09-30 | 0001628280-24-046824 |
| 2024-11-12 | 11:34 ET | [8-K](/filings/0001628280-24-046809.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-046809 |
| 2024-08-06 | 20:27 ET | [10-Q](/filings/0001628280-24-035231.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035231 |
| 2024-08-06 | 20:14 ET | [8-K](/filings/0001628280-24-035194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035194 |
| 2024-07-09 | 20:06 ET | [8-K](/filings/0001628280-24-031485.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-24-031485 |
| 2024-06-18 | 20:07 ET | [8-K](/filings/0001628280-24-028764.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-028764 |
| 2024-06-11 | 20:10 ET | [8-K](/filings/0001628280-24-027668.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-027668 |
| 2024-05-08 | 20:14 ET | [10-Q](/filings/0001628280-24-021689.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021689 |
| 2024-05-08 | 20:09 ET | [8-K](/filings/0001628280-24-021674.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021674 |
| 2024-04-29 | 20:09 ET | [DEF 14A](/filings/0001628280-24-018995.md) | Proxy statement, period 2024-06-18 | 0001628280-24-018995 |
| 2024-02-27 | 21:20 ET | [10-K](/filings/0001628280-24-007235.md) | Annual report, period 2023-12-31 | 0001628280-24-007235 |
| 2024-02-27 | 21:12 ET | [8-K](/filings/0001628280-24-007217.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-007217 |
| 2024-02-08 | 21:37 ET | [8-K](/filings/0001628280-24-003902.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-24-003902 |
| 2023-12-22 | 21:29 ET | [10-K/A](/filings/0001628280-23-042643.md) | Annual report, amended, period 2022-12-31 | 0001628280-23-042643 |
| 2023-11-07 | 21:13 ET | [10-Q](/filings/0001628280-23-037358.md) | Quarterly report, period 2023-09-30 | 0001628280-23-037358 |
| 2023-11-07 | 21:10 ET | [8-K](/filings/0001628280-23-037353.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037353 |
| 2023-08-07 | 20:09 ET | [10-Q](/filings/0001628280-23-027773.md) | Quarterly report, period 2023-06-30 | 0001628280-23-027773 |
| 2023-08-07 | 20:07 ET | [8-K](/filings/0001628280-23-027767.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027767 |
| 2023-07-06 | 20:14 ET | [8-K](/filings/0001628280-23-024454.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-024454 |
| 2023-06-30 | 20:18 ET | [8-K](/filings/0001628280-23-024042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-024042 |
| 2023-06-20 | 20:05 ET | [8-K](/filings/0001628280-23-022683.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0001628280-23-022683 |
| 2023-06-06 | 12:08 ET | [8-K](/filings/0001628280-23-021025.md) | 8.01 Other events | 0001628280-23-021025 |
| 2023-05-09 | 20:10 ET | [10-Q](/filings/0001628280-23-016816.md) | Quarterly report, period 2023-03-31 | 0001628280-23-016816 |
| 2023-05-09 | 20:03 ET | [8-K](/filings/0001628280-23-016803.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-016803 |
| 2023-04-28 | 12:04 ET | [DEF 14A](/filings/0001628280-23-013769.md) | Proxy statement | 0001628280-23-013769 |
| 2023-03-31 | 10:09 ET | [8-K](/filings/0001628280-23-010007.md) | 8.01 Other events | 0001628280-23-010007 |

Page 1 of 4. [Older](/companies/zlab/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.